Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.

Neuroreport - 17 Nov 2010

Kane Ari J, Sughrue Michael E, Rutkowski Martin J, Phillips Joanna J, Parsa Andrew T

Abstract excerpt

Epidermal growth factor module-containing mucin-like hormone receptor-3 (EMR-3) is a G-protein coupled receptor with unknown ligand and cellular function. Upregulation of EMR-3 in glioblastoma (GBM) multiforme is associated with poor survival. We investigated the expression patterns and functional significance of EMR-3 in GBM using immunohistochemistry, western blot, reverse transcription PCR, and small...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Neoplasm Invasiveness

Share to Receptors, G-Protein-Coupled

Share to Receptors, Peptide

Share to RNA Interference

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 20827226
DOI: 10.1097/WNR.0b013e32833f19f2
PMCID: PMC3064464

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.PMID 20827226Read ↗

Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.Semantic proximity Read ↗

EMP3 as a prognostic biomarker correlates with EMT in GBMSemantic proximity Read ↗

Identification of a Druggable Pathway Controlling Glioblastoma InvasivenessSemantic proximity Read ↗

Microtubule-associated NAV3 regulates invasive phenotypes in glioblastoma cells.Semantic proximity Read ↗

Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastomaSemantic proximity Read ↗

RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variantSemantic proximity Read ↗

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastomaSemantic proximity Read ↗

Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme.Semantic proximity Read ↗

Human Epidermal Growth Factor (EGF) Module-containing Mucin-like Hormone Receptor 3 Is a New Member of the EGF-TM7 Family That Recognizes a Ligand on Human Macrophages and Activated NeutrophilsSemantic proximity Read ↗

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastomaSemantic proximity Read ↗

A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1Semantic proximity Read ↗

Epidermal Growth Factor Receptor Variant III–Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate OverexpressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.